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Background: The metabolic syndrome is associated with an increased risk of development and progression of
chronic kidney disease. Renal inflammation is well known to play an important role in the initiation and progression
of tubulointerstitial injury of the kidneys. Ginger, one of the most commonly used spices and medicinal plants, has
been demonstrated to improve diet-induced metabolic abnormalities. However, the efficacy of ginger on the
metabolic syndrome-associated kidney injury remains unknown. This study aimed to investigate the impact of
ginger on fructose consumption-induced adverse effects in the kidneys.
Methods: The fructose control rats were treated with 10% fructose in drinking water over 5 weeks. The fructose
consumption in ginger-treated rats was adjusted to match that of fructose control group. The ethanolic extract of
ginger was co-administered (once daily by oral gavage). The indexes of lipid and glucose homeostasis were
determined enzymatically, by ELISA and/or histologically. Gene expression was analyzed by Real-Time PCR.
Results: In addition to improve hyperinsulinemia and hypertriglyceridemia, supplement with ginger extract (50 mg/kg)
attenuated liquid fructose-induced kidney injury as characterized by focal cast formation, slough and dilation of tubular
epithelial cells in the cortex of the kidneys in rats. Furthermore, ginger also diminished excessive renal interstitial
collagen deposit. By Real-Time PCR, renal gene expression profiles revealed that ginger suppressed fructose-stimulated
monocyte chemoattractant protein-1 and its receptor chemokine (C-C motif) receptor-2. In accord, overexpression of
two important macrophage accumulation markers CD68 and F4/80 was downregulated. Moreover, overexpressed
tumor necrosis factor-alpha, interleukin-6, transforming growth factor-beta1 and plasminogen activator inhibitor (PAI)-1
were downregulated. Ginger treatment also restored the downregulated ratio of urokinase-type plasminogen activator
to PAI-1.
Conclusions: The present results suggest that ginger supplement diminishes fructose-induced kidney injury through
suppression of renal overexpression of macrophage-associated proinflammatory cytokines in rats. Our findings provide
evidence supporting the protective effect of ginger on the metabolic syndrome-associated kidney injury.
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The metabolic syndrome is a well-established risk fac-
tor for diabetes, cardiovascular disease and mortality.
Recently, studies have suggested that the metabolic
syndrome may also contribute to the development of
chronic kidney disease. Data from the Third National
Health and Nutrition Examination Survey has shown
an independent association between the metabolic syn-
drome and chronic kidney disease [1]. This connection
has been further corroborated by the finding that the
metabolic syndrome increases the risk of developing
new-onset chronic kidney disease [2]. Indeed, renal in-
jury is often seen in various animal models of the
metabolic syndrome, such as Zucker diabetic fatty rats
[3,4] and db/db mice [5].
The Western-style diet, characterized by an overavail-
ability of food, with high intakes of high-fat foods, high-
sugar desserts and drinks, as well as high intakes of red
meat, refined grains, and high-fat dairy products, affects
multiple metabolic functions and has been associated
with a higher incidence of the metabolic syndrome. It has
been suggested that the Western-style diet is a major risk
factor for impaired kidney function and chronic kidney
disease [6]. Notably, fructose has now become a major
constituent of our modern diet. Fructose consumption has
steadily increased over the past 30 years in parallel to the
growth of the obesity/metabolic syndrome epidemic, and
fructose and high-fructose corn syrup are ingredients in
many commercially produced food products [1]. It has
been hypothesized that fructose consumption in our diet
may be among the factors that contribute to the epidemic
of the metabolic syndrome and, consequently, to the epi-
demic of chronic renal disease [1,7-11]. This hypothesis is
supported by the preliminary evidence demonstrating that
high fructose consumption induces kidney damages in
both rats [12-14] and mice [15].
Ginger (Zingiber officinale Roscoe, Zingiberacae) is
one of the most commonly used spices and medicinal
plants around the world. It has been demonstrated that
ginger has pleiotropic pharmacological activities, such
as gastrointestinal, analgesic, anti-inflammatory, antioxi-
dant and cardiovascular activities [16,17]. The renoprotec-
tive effects of ginger have also been reported in the animal
models of ischemia/reperfusion- [18,19], alcohol- [20,21],
streptozotocin- [22] and carbon tetrachloride- [23] in-
duced renal injuries. However, the efficacy of ginger on
the metabolic syndrome-associated kidney damages re-
mains unknown. We have recently demonstrated that gin-
ger supplement improves fructose consumption-induced
fatty liver [24] and adipose tissue insulin resistance [25] in
rats. In the present study, we examined the impact of gin-
ger on chronic fructose consumption-induced kidney in-
jury in rats. Furthermore, the underlying mechanisms
were also investigated.Methods
Preparation and identification of the ethanolic extract
of ginger
Ginger rhizomes were collected from the suburban area of
Hanoi, Vietnam, and identified botanically by Professor
Johji Yamahara, who is an expert in taxonomy. A voucher
specimen was deposited in Pharmafood Institute, Kyoto,
Japan (Voucher specimen No: PS0088). The extract used
in the present study was prepared using an ethanolic
method described previously [24]. Briefly, 5 kg of sliced
dry ginger rhizomes including the skins were immersed in
5 L of 95% ethanol with intermittent shaking for 24 h, and
then refluxed for 3 h by heating. The filtrate was evapo-
rated below 45°C under reduced pressure. The residue
(yield: 9.6%) was designated as an alcoholic extract. The
extract was quantified by a HPLC method described
previously [26] to contain two representative components:
6-gingerol and 6-shogaol at 4.4% and 1.1%, respectively.
Animals, diet and experimental protocol
All animal procedures were in accordance with the
‘Principles of laboratory animal care’ (http://grants1.nih.
gov/grants/olaw/references/phspol.htm) and were ap-
proved by the Animal Ethics Committee of Chongqing
Medical University, China.
Male Sprague–Dawley rats aged 7–9 weeks (210–230 g)
and standard laboratory chow were supplied by the Labora-
tory Animal Center, Chongqing Medical University, China.
Rats were housed in a temperature controlled facility (21 ±
1°C, 55 ± 5% relative humidity) with a 12-h light/dark cycle.
Animals were allowed free access to water and standard
chow for at least 1 week prior to starting the experiments.
Research has shown that sugar-sweetened nonalco-
holic beverages, such as soft drinks, appear as the major
source of fructose for all classes of age considered, ex-
cept for children younger than 6 years and adults older
than 50 years [27]. Therefore, fructose in drinking water
was used in the present study, in accordance to this ra-
tionale and the previous research protocol [24,25,28,29].
Dosage selection is of exceptional importance for
pharmacological intervention. Excessively high dosages in
animals may result in non-specific (“artificial”) effects, which
may be dissociated with those in humans. A 35-day toxicity
study in rats has demonstrated that the dried ginger powder
at the dosages of 500, 1000 and 2000 mg/kg (equivalent to
48–192 mg/kg ethanolic extract used in the present study)
was not associated with any mortalities and abnormalities in
general conditions, behavior, growth, food and water con-
sumption, hematological and blood biochemical parameters
[26]. Previous studies have reported that treatment with
dried ginger powder at a dosage of 200 [30] or 500 [31] mg/
kg (equivalent to 19.2 or 48 mg/kg ethanolic extract used in
the present study) alleviated streptozotocin-induced the
metabolic syndrome-associated or renal dysfunctions in rats.
Table 1 Primer sequences for Real Time PCR assays











Sequences: 5’ to 3’.
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864 mg ethanolic extract used in the present study) is
the officially accepted dosages (Version 1, 2010 Chinese
Pharmacopoeia). Based on the above information, the
dosages of 20 and 50 mg/kg ethanolic extract were se-
lected for the present study.
Twenty-four rats were divided into 4 groups (n = 6 per
group): (1) water control, free access to water; (2) fruc-
tose control, free access to 10% fructose solution (w/v,
preparation every day); (3) fructose + ginger 20 mg/kg
and (4) fructose + ginger 50 mg/kg. There was no differ-
ence in body weight between the groups before treat-
ments commenced. Animals in ginger-treated groups
were administered ginger extract at 20 and 50 mg/kg
(suspended in 5% Gum Arabic solution, gavage once daily)
for 5 weeks, respectively. The rats in the corresponding
water- and fructose-control groups received vehicle (5%
Gum Arabic) alone. All rats had free access to the stand-
ard chow. To avoid stress and maintain accurate monitor-
ing of fructose intake, only 2 rats were housed in a cage at
any given time. The consumed chow and fructose solutionTable 2 General parameters (n=6)
Water
Ginger 0
Fructose intake (g/2 rats/5 w) -
Chow intake (g/2 rats/5 w) 1993±100*
Body weight (g) 333±7
Epididymal fat weight (g) 4.14±0.46
Plasma glucose (mmol/L) 4.74±0.11
Plasma insulin (pmol/L) 8.57±1.10*
Plasma TG (mmol/L) 0.47±0.03*
Plasma TC (mmol/L) 1.83±0.06*
Plasma BUN (mmol/L) 6.78±0.64
Plasma creatinine (μmol/L) 45.81±6.12
TG, triglyceride; TC, total cholesterol; vs fructose control (ginger 0), *P<0.05.were measured per 2 rats daily and the intake of fructose
was calculated. Initial experiments showed that when
compared to the vehicle alone, ginger treatment signifi-
cantly increased the intake of the 10% fructose water when
the rats were given free access. In order to exclude the in-
fluence resulting from differences in fructose intake, fruc-
tose consumption in the groups treated with the ginger
extracts were adjusted by regulating the concentration of
fructose solution daily to match that of the fructose con-
trol group on the previous day.
At the end of week 4, the rats were fasted overnight
before blood samples were collected by retroorbital ven-
ous puncture under ether anesthesia at 9:00–12:00 am
for determination of plasma concentrations of total
cholesterol (kit from Kexin Institute of Biotechnology,
Shanghai, China), triglyceride (Triglyceride-E kit, Wako,
Osaka, Japan), glucose (kit from Kexin Institute of Biotech-
nology, Shanghai, China) and insulin (kit from Morinaga
Biochemical Industries, Tokyo, Japan). At the end of week
5, the rats were weighed and killed by prompt dislocation
of the neck vertebra. Kidneys and epididymal fat tissuesFructose
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body weight was calculated. Segments of kidney were flash
frozen in liquid nitrogen and stored at −80°C for subse-
quent determination of lipid contents and gene expression.
Histological examination of kidney
All slides were examined by two different researchers
in a blinded manner. Morphometric quantification was
assessed by microscopy (IX-81, Olympus Corporation,
Tokyo, Japan) using a NIH ImageJ (version 1.43) ana-
lyzing system.
A portion of kidney was fixed with 10% formalin and
embedded in paraffin. Three-micron thick sections were
cut and stained with hematoxylin and eosin. The sections
were imaged and cross-sectional areas were estimated in
glomeruli that were cut transversely. The outer borders of
the glomeruli were traced at 200 ×magnification, and
glomerular tuft area was measured. Fifty glomeruli per
kidney were counted, and the mean values of these esti-
mates were used in analyses. To further investigate the
damage, an additional section (two-micron thickness)
fixed in a 4% paraformaldehyde solution was stained with
periodic acid-Schiff (PAS) and examined as previously de-
scribed [13] using light microscopy and blinded assessors.
Tubular size was determined by outlining each tubular















































Water control Fructose  control
E FD
*
Figure 1 Kidney weight (A), the ratios of kidney weight to body weig
showing renal histology (hematoxylin and eosin, magnification: 100X
in their drinking water over 5 weeks, while the consumption of fructose in the
that of the fructose control rats. The water-control rats had free access to tapTubular injury (by counting the number of tubules that
exhibited cast formation, slough and dilation of tubular
epithelial cells) was evaluated.
To determine the degree of collagen fiber accumulation,
a kidney section (two-micron thickness) was stained with
Masson’s trichrome. Forty fields in different sections were
randomly selected, and Masson’s trichrome-stained area
(blue) and total tissue area were determined. Their ratio
was calculated as interstitial collagen deposit (fibrosis).
To observe lipid accumulation, six-micron frozen kid-
ney sections were stained with Oil Red O.
Determination of triglyceride and total cholesterol
contents in kidney
Triglyceride and total cholesterol contents in kidney were
determined as described previously [24,28]. Briefly, 100 mg
of tissue was homogenized and extracted with 2 ml of iso-
propanol. After centrifugation (1000 × g, 10 min at 4°C),
the triglyceride and total cholesterol contents in superna-
tants were determined enzymatically (Wako, Osaka, Japan).
Real-time PCR
Total RNA was isolated from kidneys of individual rats
using TRIzol (Takara, Dalian, China). cDNA was syn-
thesized using M-MLV RTase cDNA Synthesis Kit































Fructose ginger 50Fructose ginger 20
G
ht (B), glomerular tuft area (C) and representative images
, D-G) in rats. The fructose control rats had free access to 10% fructose
ginger (20 or 50 mg/kg)-treated (by gavage daily) rats was adjusted to
water. All values are means ± SEM (n = 6 each group). *P < 0.05.
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CFX 96 Real Time PCR Detection System (Biorad Labora-
tories Inc, Hercules, CA, USA) using the SYBR® Premix
Ex Taq™ II (Takara, Dalian, China). The sequences of
primers are shown in Table 1. The gene expression from
each sample was analysed in duplicates and normalized
against the internal control gene β-actin. Levels in water
control rats were arbitrarily assigned a value of 1.
Data analysis
All results are expressed as means ± SEM. Data were ana-
lyzed by ANOVA using the StatView software (Version
5.0.1, SAS Institute Inc. USA), and followed by The
Student-Newman-Keuls test to locate the differences be-
tween groups. P < 0.05 was considered to be statistically
significant.
Results
General characteristics of the effects of ginger extract in
fructose-fed rats
Compared to water drinking, intake of 10% fructose so-
lution decreased intake of chow (Table 2). After 4-week
supplementing with fructose, plasma concentrations of






























































Figure 2 Damaged tubules characterized by focal cast formation, slou
outer of stripe (B), and size of proximal and distal tubes in the cortex
10% fructose in their drinking water over 5 weeks, while the consumption
rats was adjusted to that of the fructose control rats. The water-control rats
group). *P < 0.05.whereas glucose concentration remained unchanged
(Table 2). Rats in the fructose control and fructose gin-
ger (20 and 50 mg/kg) groups showed similar intakes of
fructose and chow. However, supplementing with a gin-
ger extract at 50 mg/kg significantly decreased plasma
concentrations of glucose, insulin and triglyceride, but
it did not affect plasma total cholesterol concentration
in fructose-fed rats (Table 2). Ginger extract at 20 mg/
kg showed minimal effect across all parameters shown
in Table 2.
Effects on kidney-related variables in rats
Fructose feeding did not significantly affect plasma BUN
and creatinine (Table 2), body weight (Table 2) and glom-
erular tuft area (Figure 1C, D-G) in rats. However, it de-
creased kidney weight (Figure 1A) and the ratio of kidney
weight to body weight (Figure 1B). Supplementing with a
ginger extract at 20 and 50 mg/kg did not significantly
affect these parameters in fructose-fed rats (Table 2,
Figures 1A-G).
Importantly, fructose induced a pronounced increase in
tubular damage in both the cortex and outer stripe of the
medullas characterized by the focal cast formation, slough





































gh and dilation of tubular epithelial cells in the cortex (A) and
(C) of kidney in rats. The fructose control rats had free access to
of fructose in the ginger (20 or 50 mg/kg)-treated (by gavage daily)
had free access to tap water. All values are means ± SEM (n = 6 each
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creased the size of proximal, but not distal tubules in the
cortex (Figure 2C, Figures 3A-H). Treatment with ginger
extract at 50 mg/kg significantly decreased the damage of
tubules in the cortex, but not in the outer stripe of the me-
dullas (Figures 2A and B). Furthermore, this supplement
decreased the enlargement of proximal tubules, whereas
the size of distal tubules in the cortex was not affected
(Figure 2C, Figures 3A-H). Ginger extract at 20 mg/kg
failed to significantly affect these variables (Figures 2A-C,
Figures 3B and C, and Figures 3F and G).
In addition, fructose feeding increased the ratio of
the Masson’s trichrome-stained area to total tissue area
in the renal interstitium (Figures 4A-C). Supplement-
ing with a ginger extract at 50 mg/kg significantly
inhibited this increase (Figures 4A, C and E), whereas
the lower dosage of ginger extract showed minimal ef-
fect (Figures 4A, C and D).B CA
F GE
Water control Fructose  control
Water control Fructose  control
Figure 3 Representative images showing tubular damages characteri
epithelial cells (with ※, periodic acid-Schiff staining, magnification: 40
had free access to 10% fructose in their drinking water over 5 weeks, while
(by gavage daily) rats was adjusted to that of the fructose control rats. TheIn contrast to the tubular injury and interstitial fibro-
sis, renal triglyceride (Figure 5A) and total cholesterol
(Figure 5B) contents were not altered by fructose feeding.
Unchanged lipid accumulation was further confirmed by
Oil Red O staining (Figures 5C and D). Treatment with a
ginger extract at either low or high dosage did not affect
renal lipid contents in fructose-fed rats (Figures 5A, B, E
and F).
Renal gene expression profiles in rats
As the supplement with ginger extract at 20 mg/kg showed
negligible effects on all phenotypic parameters, compari-
sons in gene expression were restricted to water control,
fructose control and fructose ginger 50 mg/kg groups.
By real-time PCR, fructose feeding increased renal ex-
pression of mRNAs corresponding to monocyte chemo-
tactic protein (MCP)-1 (Figure 6A), chemokine (C-C
motif) receptor (CCR)-2 (Figure 6B), CD68 (Figure 6C),D
H
Fructose ginger 50Fructose ginger 20
Fructose ginger 50Fructose ginger 20
zed by focal cast formation, slough and dilation of tubular
0X) in the cortex of kidney in rats (A-H). The fructose control rats
the consumption of fructose in the ginger (20 or 50 mg/kg)-treated







































B C D E
Water control Fructose  control Fructose ginger 50Fructose ginger 20
Ginger
Figure 4 The ratio of Masson’s trichrome-stained area to total tissue area in the renal interstitium (A) and representative images showing
Masson’s trichrome-stained interstitial collagen deposit (Blue) (magnification: 400×) in the kidney of rats (B-E). The fructose control rats
had free access to 10% fructose in their drinking water over 5 weeks, while the consumption of fructose in the ginger (20 or 50 mg/kg)-treated
(by gavage daily) rats was adjusted to that of the fructose control rats. The water-control rats had free access to tap water. All values are
means ± SEM (n = 6 each group). *P < 0.05.
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http://www.biomedcentral.com/1472-6882/14/174F4/80 (Figure 6D), TNF-α (Figure 7A), IL-6 (Figure 7B),
transforming growth factor (TGF)-β1 (Figure 7C) and
plasminogen activator inhibitor (PAI)-1 (Figure 7D). Al-
though urokinase-type plasminogen activator (uPA) was
not altered (Figure 7E), the ratio of uPA to PAI-1 expres-
sion was significantly downregulated by fructose feeding
(Figure 7F). Ginger supplement substantially sup-
pressed renal overexpression of MCP-1, CCR-2, CD68,
F4/80, TNF-α, IL-6, TGF-β1 and PAI-1 (Figures 6A-D
and Figures 7A-D), and restored the downregulated ra-
tio of uPA to PAI-1 (Figure 7F).
Discussion
Ginger has been demonstrated to protect rats from ische-
mia/reperfusion- [18,19], alcohol- [20,21], streptozotocin-
[22] and carbon tetrachloride- [23] induced renal injuries.
Recently, we have demonstrated that ginger supplement
improves fructose consumption-induced fatty liver [24]and adipose tissue insulin resistance [25] in rats. The
present study investigated the effects of ginger on chronic
fructose consumption-associated kidney injury. Consistent
with the previous findings [13], the present results demon-
strate that five-week fructose consumption induced kidney
remodeling as characterized by focal cast formation,
slough and dilation of tubular epithelial cells in the cor-
tex and outer stripe of the medullas, and excessive
interstitial collagen deposit in rats. However, these
pathological changes were accompanied by minimal al-
teration in glomerular structure and concentrations of
BUN and plasma creatinine. It is possible that the mild
initial histological changes do not induce pronounced
alterations in renal functionality. Supplementing with a
ginger extract (50 mg/kg) attenuated the proximal tubu-
lar damage and interstitial fibrosis in the kidneys and
these effects were accompanied by improvements in

























































C D E F
Water control Fructose  control Fructose ginger 50Fructose ginger 20
Figure 5 Renal triglyceride (A) and total cholesterol (B) contents, and representative images showing histology of kidney (C-F, Oil Red
O staining, 400X) in rats. The fructose control rats had free access to 10% fructose in their drinking water over 5 weeks, while the consumption
of fructose in the ginger (20 or 50 mg/kg)-treated (by gavage daily) rats was adjusted to that of the fructose control rats. The water-control rats
had free access to tap water. All values are means ± SEM (n = 6 each group). *P < 0.05.
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http://www.biomedcentral.com/1472-6882/14/174these results present evidence suggesting that ginger
possesses protective effect against the initial stages of
the metabolic syndrome-associated kidney injury.
Renal inflammation is known to play an important
role in the initiation and progression of tubulointersti-
tial injury in the kidneys [32,33]. Fructose has been
demonstrated to induce production of macrophage-
associated MCP-1 in human kidney proximal tubular
cells [34]. Fructose consumption leads to cortical tubu-
lar damage with inflammatory infiltrates [12]. MCP-1 pro-
motes monocyte and macrophage migration and activation,
and upregulates expression of adhesion molecules and
other proinflammatory cytokines. Studies indicate that the
local expression of MCP-1 at sites of renal injury promotes
macrophage adhesion and chemotaxis through ligation of
CCR-2 [35]. In patients, tubular MCP-1 is elevated in
progressive renal diseases [36] and albuminuria is associ-
ated with MCP-1 and macrophage infiltration [37]. Theinfiltrated macrophages produce numerous proinflamma-
tory cytokines, such as TNF-α [38], which has been shown
to mediate inflammation in several models of renal injury,
including tubulointerstitial injury [39]. It has been reported
that gingerols, [6]-shogaol and 1-dehydro-[10]-gingerdione
inhibit lipopolysaccharide-stimulated release and gene ex-
pression of proinflammatory cytokines including MCP-1
and IL-6 in RAW 264.7 macrophages and cultured primary
rat astrocytes [40-43]. In addition, another component of
ginger, known as zingerone, has also been shown to sup-
press the inflammatory action of macrophages and release
of MCP-1 from adipocytes, thereby blunting the inflam-
matory response of adipose tissue in obesity [44]. These
findings have been corroborated by a study we have re-
cently conducted in rats demonstrating the modulatory
effects of ginger on adipose expression of macrophage-
related proinflammatory cytokines thereby ameliorating



















































































Figure 6 Renal mRNA expression of monocyte chemotactic protein (MCP)-1 (A), chemokine (C-C motif) receptor (CCR)-2 (B), CD68 (C)
and F4/80 (D) in rats. The fructose control rats had free access to 10% fructose in their drinking water over 5 weeks, while the consumption of
fructose in the ginger (20 or 50 mg/kg)-treated (by gavage daily) rats was adjusted to that of the fructose control rats. The water-control rats had
free access to tap water. mRNA was determined by Real-Time PCR. Levels in water-control rats were assigned a value of 1. All values are means ±
SEM (n = 6 each group). *P < 0.05.
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[6]-gingerol and [6]-shogaol was able to suppress
fructose-induced overexpression of MCP-1, CCR-2,
CD68 and F4/80 (two important macrophage markers
[45,46]), TNF-α and IL-6 in the kidneys. These findings
are consistent with the attenuation of proximal tubular
injury. Thus, the renoprotective effect of ginger supple-
ment is associated with suppression of renal overexpression
of macrophage-associated proinflammatory cytokines.
Proinflammatory cytokines are associated with renal fi-
brosis. It has been demonstrated that blockading MCP-1
and its receptor CCR-2 pathway reduces renal fibrosis
[47]. The activated macrophages also produce other pro-
inflammatory cytokines, such as IL-6, TGF-β1 and PAI-1
[38]. IL-6 was shown to enhance TGF-β1 signaling via
modulation of TGF-β1 receptor trafficking, an effect that
may enhance renal fibrosis [48]. TGF-β1 may activate
the plasmin system by stimulating gene expression of
PAI-1, the principal inhibitor of plasminogen activation
[49]. PAI-1 has a number of important roles in patho-
physiological processes, such as inhibition of fibrinolysis,
regulation of extracellular matrix turnover and activationof proenzymes and latent growth factors that promote tis-
sue fibrosis and sclerosis [48]. In progressive renal dis-
eases, PAI-1 has been identified as a critical mediator of
glomerulosclerosis and interstitial fibrosis [50,51]. The al-
tered uPA to PAI-1 ratio reflects a change from a profibri-
nolytic to an antifibrinolytic state [52]. The shift toward
the uPA-enriched profibrinolytic state favors renal colla-
gen degradation. Given its pathophysiological role, studies
into TGF-β1 have found that [6]-gingerol inhibits its
stimulation of myofibroblast differentiation and collagen
production in nasal polyp-derived fibroblasts [53] and of
proteoglycan core protein synthesis in human vascular
smooth muscle cells [54]. In the present study, fructose-
induced upregulation of MCP-1, CCR-2, IL-6, TGF-β1
and PAI-1 gene expression in kidney was suppressed by
ginger supplement (50 mg/kg). The ratio of uPA to PAI-1
was also restored. Thus, ginger-elicited diminishment of
renal interstitial fibrosis is also associated with suppression
of renal overexpression of proinflammatory cytokines,
thereby improving profibrinolytic state.
Lipid accumulation in nonadipose tissues has been

























































































































Figure 7 Renal mRNA expression of tissue necrosis factor (TNF)-α (A), interleukin (IL)-6 (B), transforming growth factor (TGF)-β1 (C),
plasminogen activator inhibitor (PAI)-1 (D), urokinase-type plasminogen activator (uPA) (E) and the ratio of uPA to PAI-1 (F) in rats.
The fructose control rats had free access to 10% fructose in their drinking water over 5 weeks, while the consumption of fructose in the ginger
(20 or 50 mg/kg)-treated (by gavage daily) rats was adjusted to that of the fructose control rats. The water-control rats had free access to tap
water. mRNA was determined by Real-Time PCR. Levels in water-control rats were assigned a value of 1. All values are means ± SEM (n = 6 each
group). *P < 0.05.
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tial evidence that excess renal lipids can cause injury in
animal models of metabolic disease (obesity, metabolic
syndrome and diabetes mellitus), chronic kidney disease,
acute renal injury of several etiologies, as well as aging
[55]. Lipotoxic cellular dysfunction and injury occur
through several mechanisms such as release of proin-
flammatory and profibrotic factors [55]. Fructose con-
sumption may induce excessive lipid accumulation in
liver [27]. We have recently demonstrated that treatment
with the ethanolic extract of ginger attenuates fructose-
induced fatty liver in rats [24]. In the present study,
however, five-week fructose feeding did not alter renal ac-
cumulation of triglyceride and total cholesterol in rats.
Ginger treatment (20 and 50 mg/kg) also did not affect
renal lipid contents in fructose-fed rats. Thus, it is unlikely
that ginger treatment ameliorates fructose-induced renal
injury in rats via modification of renal lipid metabolism.
While there are numerous constituents in ginger, the
two prominent components [6]-gingerol and [6]-shogaol
have been implicated in the majority of pharmacological
activities associated with ginger [16]. At this point, further
investigation is needed to broaden our collective know-
ledge regarding the details surrounding the therapeuticactions of ginger. Specifically, whether [6]-gingerol, [6]-
shogaol, or a combination thereof is responsible for the di-
minishment of fructose-induced renal injury, their specific
function on macrophages, and the manner in which they
suppress proinflammatory cytokines.Conclusion
Our present results demonstrate that supplement with
ginger extract at 50 mg/kg attenuates chronic fructose
consumption-induced kidney injury in rats by suppressing
renal overexpression of proinflammatory cytokines. Our
findings provide evidence supporting the benefit of ginger
supplement for the metabolic syndrome-associated kidney
injury.Abbreviations
BUN: Blood urea nitrogen; BW: Body weight; CCR: Chemokine (C-C motif)
receptor; IL: Interleukin; MCP: Monocyte chemoattractant protein;
PAI: Plasminogen activator inhibitor; PAS: Periodic acid-schiff;
TGF: Transforming growth factor; TNF: Tumor necrosis factor;
uPA: Urokinase-type plasminogen activator.Competing interests
The authors have declared that no conflict of interest exists.
Yang et al. BMC Complementary and Alternative Medicine 2014, 14:174 Page 11 of 12
http://www.biomedcentral.com/1472-6882/14/174Authors’ contribution
CL and MY performed the experiments, analyzed/interpreted data and
drafted the manuscript. JJ, GZ, XL and JY analyzed/interpreted data. JW and
YL contributed to the concept, designed experiments, analyzed/interpreted
data and finalized the manuscript. All coauthors reviewed and discussed the
paper. All authors read and approved the final manuscript.
Acknowledgments
We thank Mr. Alan Yeung for his excellent assistance in the preparation of
this manuscript. This work was financially supported by National Natural
Science Foundation of China (Grant 81374033), China, and R&D Agency for
Curative Natural Products (a Japanese government-registered non-profit
organization), Kyoto, Japan.
Author details
1Faculty of Basic Medical Sciences, Chongqing Medical University,
Chongqing 400016, China. 2College of Laboratory Medicine, Chongqing
Medical University, Chongqing 400016, China. 3Endocrinology and
Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of
Traditional Chinese Medicine, Sydney, NSW 2000, Australia. 4Pharmafood
Institute, Kyoto 602-8136, Japan. 5Department of Traditional Chinese
Medicine, Chongqing Medical University, Chongqing 400016, China.
Received: 6 December 2013 Accepted: 20 May 2014
Published: 27 May 2014
References
1. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK,
He J: The metabolic syndrome and chronic kidney disease in US adults.
Ann Intern Med 2004, 140:167–174.
2. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for
chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005,
16:2134–2140.
3. Li Y, Qi Y, Kim MS, Xu KZY, Huang THW, Rong X, Murray M, Yamahara J:
Increased renal collagen cross-linking and lipid accumulation in
nephropathy of Zucker diabetic fatty rats. Diabetes-metab Res Rev 2008,
24:498–506.
4. He L, Qi Y, Rong X, Jiang J, Yang Q, Yamahara J, Murray M, Li Y: The
Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in
rats: suppression of angiotensin II/AT1 signaling. Evid-Based Complement
Alternat Med 2011, 2011:807451.
5. Ziyadeh FN, Hoffman BB, Han DC, La Cruz MC I-D, Hong SW, Isono M, Chen S,
McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess
matrix gene expression, and glomerular mesangial matrix expansion by
treatment with monoclonal anti-transforming growth factor-antibody in
db/db diabetic mice. Proc Natl Acad Sci USA 2000, 97:8015–8020.
6. Odermatt A: The Western-style diet: a major risk factor for impaired kidney
function and chronic kidney disease. Am J Physiol Renal Physiol 2011,
301:F919–F931.
7. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ: Fructose, weight gain, and the
insulin resistance syndrome. Am J Clin Nutr 2002, 76:911–922.
8. Jacobson MF: High-fructose corn syrup and the obesity epidemic.
Am J Clin Nutr 2004, 80:1081–1082.
9. Jürgens H, Haass W, Castaneda TR, Schürmann A, Koebnick C, Dombrowski F,
Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HJ, Havel PJ,
Tschöp MH: Consuming fructose‐sweetened beverages increases body
adiposity in mice. Obes Res 2005, 13:1146–1156.
10. Nakagawa T, Tuttle KR, Short RA, Johnson RJ: Hypothesis: fructoseinduced
hyperuricemia as a causal mechanism for the epidemic of the metabolic
syndrome. Nat Clin Pract Nephrol 2005, 1:80–86.
11. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X,
Feig DI, Block ER, Herrera-Acosta J, Johnson RJ: A causal role for uric acid
in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006,
290:F625–F631.
12. Kizhner T, Werman MJ: Long-term fructose intake: biochemical
consequences and altered renal histology in the male rat.
Metabolism 2002, 51:1538–1547.
13. Nakayama T, Kosugi T, Gersch M, Connor T, Sanchez-Lozada LG, Lanaspa MA,
Roncal C, Perez-Pozo SE, Johnson RJ, Nakagawa T: Dietary fructose causes
tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol 2010,
2010(298):F712–F720.14. Oudot C, Lajoix AD, Jover B, Rugale C: Dietary sodium restriction prevents
kidney damage in high fructose-fed rats. Kidney Int 2013, 83:674–683.
15. Aoyama M, Isshiki K, Kume S, Chin-Kanasaki M, Araki H, Araki SI, Koya D, Haneda M,
Kashiwagi A, Maegawa H, Uzu T: Fructose induces tubulointerstitial injury in the
kidney of mice. Biochem Biophys Res Commun 2012, 419:244–249.
16. Ali BH, Blunden G, Tanira MO, Nemmar A: Some phytochemical,
pharmacological and toxicological properties of ginger (Zingiber
officinale Roscoe): a review of recent research. Food Chem Toxicol 2008,
46:409–420.
17. Nicoll R, Henein MY: Ginger (Zingiber officinale Roscoe): A hot remedy for
cardiovascular disease? Int J Cardiol 2009, 131:408–409.
18. Uz E, Karatas OF, Mete E, Bayrak R, Bayrak O, Atmaca AF, Atis O, Yildirim ME,
Akcay A: The effect of dietary ginger (Zingiber officinals Rosc) on renal
ischemia/reperfusion injury in rat kidneys. Ren Fail 2009, 31:251–260.
19. Maghsoudi S, Gol A, Dabiri S, Javadi A: Preventive effect of ginger
(Zingiber officinale) pretreatment on renal ischemia-reperfusion in rats.
Eur Surg Res 2011, 46:45–51.
20. Shanmugam KR, Ramakrishna CH, Mallikarjuna K, Reddy KS: Protective
effect of ginger against alcohol-induced renal damage and antioxidant
enzymes in male albino rats. Indian J Exp Biol 2010, 48:143–149.
21. Ramudu SK, Korivi M, Kesireddy N, Chen CY, Kuo CH, Kesireddy S: Ginger
feeding protects against renal oxidative damage caused by alcohol
consumption in rats. J Ren Nutr 2011, 21:263–270.
22. Ramudu SK, Korivi M, Kesireddy N, Lee LC, Cheng IS, Kuo CH, Kesireddy SR:
Nephro-protective effects of a ginger extract on cytosolic and
mitochondrial enzymes against streptozotocin (STZ)-induced diabetic
complications in rats. Chin J Physiol 2011, 54:79–86.
23. Hamed MA, Ali SA, El-Rigal NS: Therapeutic potential of ginger against
renal injury induced by carbon tetrachloride in rats. ScientificWorldJournal
2012, 2012:840421.
24. Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, Li Y: Treatment with
ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia
in rats: modulation of the hepatic carbohydrate response element binding
protein-mediated pathway. Evid-Based Complement Alternat Med 2012,
2012:570948.
25. Wang J, Gao H, Ke D, Zuo G, Yang Y, Yamahara J, Li Y: Improvement of liquid
fructose-induced adipose tissue insulin resistance by ginger treatment
in rats is associated with suppression of adipose macrophage-related
pro-inflammatory cytokines. Evid-Based Complement Alternat Med 2013,
2013:590376.
26. Rong X, Peng G, Suzuki T, Yang Q, Yamahara J, Li Y: A 35-day gavage safety
assessment of ginger in rats. Regul Toxicol Pharmacol 2009, 54:118–123.
27. Tappy L, Lê KA: Metabolic effects of fructose and the worldwide increase
in obesity. Phys Rev 2010, 90:23–46.
28. Liu C, Li Y, Zuo G, Xu W, Gao H, Yang Y, Yamahara J, Wang J, Li Y: Oleanolic
acid diminishes liquid fructose-induced fatty liver in rats: role of
modulation of hepatic sterol regulatory element-binding protein
1c-mediated expression of genes responsible for de novo fatty acid
synthesis. Evid-Based Complement Alternat Med 2013, 2013:534084.
29. Liu L, Yang M, Lin X, Li Y, Liu C, Yang Y, Yamahara J, Wang J, Li Y:
Modulation of hepatic sterol regulatory element-binding protein-1c-
mediated gene expression contributes to Salacia oblonga root-elicited
improvement of fructose-induced fatty liver in rats. J Ethnopharmacol 2013,
150:1045–1052.
30. Madkor HR, Mansour SW, Ramadan G: Modulatory effects of garlic, ginger,
turmeric and their mixture on hyperglycaemia, dyslipidaemia and
oxidative stress in streptozotocin-nicotinamide diabetic rats. Br J Nutr 2011,
105:1210–1217.
31. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M: Anti-diabetic
and hypolipidaemic properties of ginger (Zingiber officinale) in
streptozotocin-induced diabetic rats. Br J Nutr 2006, 96:660–666.
32. Goor HV, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR:
Macrophages and renal disease. Lab Invest 1994, 71:456–464.
33. Eardley KS, Cockwell P: Macrophages and progressive tubulointerstitial
disease. Kidney Int 2005, 68:437–455.
34. Cirillo P, Gersch MS, Mu W, Scherer PM, Kim KM, Gesualdo L, Henderson GN,
Johnson RJ, Sautin YY: Ketohexokinase-dependent metabolism of
fructose induces proinflammatory mediators in proximal tubular cells.
J Am Soc Nephrol 2009, 20:545–553.
35. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y,
Asano M, Wang H, Matsushima K, Takeya M, Kuziel WA, Mukaida N, Yokoyama H:
Yang et al. BMC Complementary and Alternative Medicine 2014, 14:174 Page 12 of 12
http://www.biomedcentral.com/1472-6882/14/174CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc
Nephrol 2003, 14:2503–2515.
36. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra F,
Schena FP: Monocyte chemotactic peptide-1 expression in acute and
chronic human nephritides: a pathogenetic role in interstitial monocytes
recruitment. J Am Soc Nephrol 1996, 7:906–913.
37. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ,
Adu D, Cockwell P: The relationship between albuminuria, MCP-1/CCL2, and
interstitial macrophages in chronic kidney disease. Kidney Int 2006,
69:1189–1197.
38. Galkina E, Ley K: Leukocyte recruitment and vascular injury in diabetic
nephropathy. J Am Soc Nephrol 2006, 17:368–377.
39. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S: Contributions of
angiotensin II and tumor necrosis factor-alpha to the development of
renal fibrosis. Am J Physiol Renal Physiol 2001, 280:F777–F785.
40. Tripathi S, Maier KG, Bruch D, Kittur DS: Effect of 6-gingerol on pro-
inflammatory cytokine production and costimulatory molecule
expression in murine peritoneal macrophages. J Surg Res 2007,
138:209–213.
41. Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN:
Comparative antioxidant and anti-inflammatory effects of [6]-gingerol,
[8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol 2010,
127:515–520.
42. Shim S, Kim S, Choi DS, Kwon YB, Kwon J: Anti-inflammatory effects of
[6]-shogaol: potential roles of HDAC inhibition and HSP70 induction.
Food Chem Toxicol 2011, 49:2734–2740.
43. Lee HY, Park SH, Lee M, Kim HJ, Ryu SY, Kim ND, Hwang BY, Hong JT, Han SB,
Kim Y: 1-Dehydro-[10]-gingerdione from ginger inhibits IKKβ activity for
NF-κB activation and suppresses NF-κB-regulated expression of inflammatory
genes. Br J Pharmacol 2012, 167:128–140.
44. Woo HM, Kang JH, Kawada T, Yoo H, Sung MK, Yu R: Active spice-derived
components can inhibit inflammatory responses of adipose tissue in
obesity by suppressing inflammatory actions of macrophages and
release of monocyte chemoattractant protein-1 from adipocytes.
Life Sci 2007, 80:926–931.
45. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM,
Ranganathan G, Peterson CA, McGehee RE, Kern PA: Expression of CD68
and macrophage chemoattractant protein-1 genes in human adipose
and muscle tissues: association with cytokine expression, insulin resistance,
and reduction by pioglitazone. Diabetes 2005, 54:2305–2313.
46. Galic S, Fullerton MD, Schertzer JD, Sikkema S, Marcinko K, Walkley CR, Izon D,
Honeyman J, Chen ZP, Van Denderen BJ, Kemp BE, Steinberg GR: Hematopoietic
AMPK β1 reduces mouse adipose tissue macrophage inflammation and
insulin resistance in obesity. J Clin Invest 2011, 121:4903–4915.
47. Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya
M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H: Blockade of CCR2
ameliorates progressive fibrosis in kidney. Am J Pathol 2004, 165:237–246.
48. Zhang XL, Topley N, Ito T, Phillips A: Interleukin-6 regulation of
transforming growth factor (TGF)-beta receptor compartmentalization
and turnover enhances TGF-beta1 signaling. J Biol Chem 2005,
280:12239–12245.
49. Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O,
Blasi F, Danø K: Transforming growth factor-beta is a strong and fast acting
positive regulator of the level of type-1 plasminogen-activator inhibitor
messenger-RNA in Wi-38 human lung fibroblasts. EMBO J 1987, 6:1281–1286.
50. Eddy AA: Plasminogen activator inhibitor-1 and the kidney.
Am J Physiol 2002, 283:F209–F220.
51. Fogo AB: Renal fibrosis: not just PAI-1 in the sky. J Clin Invest 2003,
112:326–328.
52. Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR:
Vein wall remodeling after deep vein thrombosis involves matrix
metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 2005,
42:140–148.
53. Park SA, Park IH, Cho JS, Moon YM, Lee SH, Kim TH, Lee SH, Lee HM: Effect
of [6]-gingerol on myofibroblast differentiation in transforming growth
factor beta 1-induced nasal polyp-derived fibroblasts. Am J Rhinol
Allergy 2012, 26:97–103.54. Kamato D, Babaahmadi Rezaei H, Getachew R, Thach L, Guidone D, Osman N,
Roufogalis B, Duke CC, Tran VH, Zheng W, Little PJ: (S)-[6]-Gingerol inhibits
TGF-β-stimulated biglycan synthesis but not glycosaminoglycan
hyperelongation in human vascular smooth muscle cells. J Pharm Pharmacol
2013, 65:1026–1036.
55. Bobulescu IA: Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol
Hypertens 2010, 19:393–402.
doi:10.1186/1472-6882-14-174
Cite this article as: Yang et al.: Ginger extract diminishes chronic
fructose consumption-induced kidney injury through suppression of renal
overexpression of proinflammatory cytokines in rats. BMC Complementary
and Alternative Medicine 2014 14:174.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
